Covalent binding of hexachlorobutadiene metabolites to renal and hepatic mitochondrial DNA
Abstract:
The covalent binding of [14C]hexachlorobutadiene (HCBD) metabolites to DNA was investigated in mouse liver and kidney after application of a single oral dose of 30 mg/kg. A low level of binding of [14C]HCBD metabolites to nuclear DNA (nDNA) from kidney with a covalent binding index (CBI) of 27 was detectable, whereas nDNA from liver did not retain radioactivity significantly exceeding background activity (background CBInDNA = 6 and CBImtDNA = 60). Considerably higher binding of metabolites to mitochondrial DNA (mtDNA) from liver (CBI = 500) and kidney (CBI = 7500) could be demonstrated. Enzymatic hydrolysis followed by HPLC fractionation of mtDNA from mouse kidney revealed the presence of three radioactive compounds which may represent DNA bases altered by HCBD metabolites. The observed binding of HCBD metabolites to DNA constituents in vivo suggests that genotoxic mechanisms are operative in initiating HCBD nephrocarcinogenesis.
Insights
Hexachlorobutadiene (HCBD) metabolites bind to mouse DNA, particularly mitochondrial DNA in the kidney. This DNA binding suggests genotoxic mechanisms may initiate HCBD-induced kidney cancer.
Area of Science:
- Toxicology
- Molecular Biology
- Carcinogenesis
Background:
- Hexachlorobutadiene (HCBD) is an industrial chemical with known toxicity.
- Understanding the molecular mechanisms of HCBD toxicity is crucial for risk assessment.
Purpose of the Study:
- To investigate the covalent binding of [14C]hexachlorobutadiene (HCBD) metabolites to nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) in mouse liver and kidney.
- To explore the potential genotoxic mechanisms underlying HCBD-induced nephrocarcinogenesis.
Main Methods:
- Administration of a single oral dose of [14C]HCBD (30 mg/kg) to mice.
- Quantification of radioactivity in isolated nDNA and mtDNA from liver and kidney.
- Enzymatic hydrolysis and HPLC fractionation of mtDNA to identify bound metabolites.
Main Results:
- Low binding of HCBD metabolites to kidney nDNA (CBI = 27), with minimal binding to liver nDNA.
- Significant binding of HCBD metabolites to liver mtDNA (CBI = 500) and kidney mtDNA (CBI = 7500).
- Identification of three radioactive compounds in kidney mtDNA, suggesting altered DNA bases.
Conclusions:
- HCBD metabolites exhibit significant covalent binding to mtDNA in mouse liver and kidney.
- The observed DNA binding in vivo supports the hypothesis that genotoxic mechanisms are involved in HCBD nephrocarcinogenesis.
More Related Videos
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Animal Mitochondrial Genetics
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
π Molecular Orbitals of 1,3-Butadiene
The simplest conjugated diene is 1,3-butadiene: a four-carbon system where each carbon is sp2-hybridized and has an unhybridized p orbital that contains an unpaired electron. According to molecular orbital theory, atomic orbitals combine to form molecular orbitals such that the number...
Stability of Conjugated Dienes
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Bioactivation and Tissue Toxicity
